Aversion Therapy for Bacteria: Repurposing Aurodox

Hoskisson, Paul (Principal Investigator)

Project: Research

Status	Active
Effective start/end date	1/09/21 → 31/08/24

Funding

MRC (Medical Research Council): £69,404.92

1 Article

Biosynthesis of aurodox, a Type III secretion system inhibitor from Streptomyces goldiniensis
McHugh, R. E., Munnoch, J. T., Braes, R. E., McKean, I. J. W., Giard, J., Taladriz-Sender, A., Peschke, F., Burley, G. A., Roe, A. J. & Hoskisson, P. A., 9 Aug 2022, In: Applied and Environmental Microbiology. 88, 15, 11 p., e00692-22.
Research output: Contribution to journal › Article › peer-review

Open Access
File
7 Downloads (Pure)